Umbilical cord blood stem cell transplantation and endovascular treatment of diabetic lower limb ischemic disease
10.3969/j.issn.2095-4344.2015.23.025
- VernacularTitle:脐血干细胞移植及血管成形治疗糖尿病下肢缺血性疾病
- Author:
Hongfang MA
;
Fujun WANG
- Publication Type:Journal Article
- Keywords:
Cord Blood Stem Cell Transplantation;
Diabetic Angiopathies;
Angioplasty
- From:
Chinese Journal of Tissue Engineering Research
2015;(23):3755-3760
- CountryChina
- Language:Chinese
-
Abstract:
BACKGROUND:In recent years, interventional therapy because of its high success rate, good curative effect, little trauma has been widely recognized, but vascular intimal injury due to interventional therapy stil has no effective treatment, resulting in long-term postoperative severe restenosis. Stem cel transplantation has brought a new drawn for the repair of impaired endothelial function, reendothelialization and aided restoration of the blood supply to ischemic tissues. OBJECTIVE: To summarize the recent progress in umbilical cord blood stem cels transplantation and endovascular treatment for treatment of diabetic lower limb ischemic disease. METHODS: A computer-based search of PubMed and CNKI was performed for relevant articles published from January 2000 to March 2015 using the keywords of “umbilical cord blood stem cel transplantation, percutaneous transluminal angioplasty, diabetic lower limb ischemia, restenosis” in English and Chinese. Totaly 216 relevant literatures were initialy obtained, and 44 articles were ultimately included. RESULTS AND CONCLUSION:By comparing the therapeutic efficacy and long-term prognosis of umbilical cord blood stem cel transplantation and endovascular treatment, it is concluded that umbilical cord blood stem cel transplantation combined with endovascular treatment is better than either of them alone, which can promote the establishment of colateral circulation, improve the impaired endothelial function and reduce the occurrence of restenosis after interventional therapy.
